indolent systemic mastocytosis

Blueprint's Ayvakit picks up long-awaited FDA approval in indolent systemic mastocytosis
Fierce Pharma
Mon, 05/22/23 - 10:07 pm
Blueprint Medicines
Ayvakit
FDA
indolent systemic mastocytosis
systemic mastocytosis